Recent findings indicate that early B-cell factor 1 (EBF1), a transcription factor essential for cell differentiation and maturation, exhibits a comparable yet more intricate and variable mechanism of action in solid tumors compared to hematological cancers. Here, EBF1 is linked to hematopoietic and lymphoid cell neoplasm.